Tivozanib |
AV-951; KRN-951; ASP-4130; Kil-8951 |
Approved |
Kyowa Hakko Kirin Co Ltd |
Fotivda |
United States |
Carcinoma, Renal Cell |
Aveo Pharmaceuticals Inc |
2017-08-24 |
Carcinoma, Renal Cell |
Details
|
Fruquintinib |
HMPL-013 |
Approved |
Hutchison Medipharma Ltd |
爱优特, Elunate |
Macau |
Colorectal Neoplasms |
Hutchison Huangpu Medicine (Shanghai) Co Ltd |
2018-09-04 |
Solid tumours; Biliary Tract Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Rectal Neoplasms; Neoplasms; Colonic Neoplasms; Kidney Diseases; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Sarcoma; Breast Neoplasms; Colorectal Neoplasms; Hepatic Insufficiency; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Sorafenib Tosylate |
NSC-724772; BAY-43-0006; BAY-43-9006; BAY-54-9085 |
Approved |
Onyx Pharmaceuticals Inc |
Nexavar, 多吉美 |
EU |
Thyroid Neoplasms |
Bayer AG |
2005-12-01 |
Lung Neoplasms; Adrenocortical Carcinoma; Mesothelioma; Breast Neoplasms; Hepatitis B; Prostatic Neoplasms; Brain Neoplasms; Sarcoma; Pulmonary Arterial Hypertension; Medullary thyroid cancer (MTC); Hepatitis C; Thyroid Neoplasms; Leukemia, Monocytic, Acute; Lymphoma, T-Cell; Digestive System Neoplasms; Leukemia, Myeloid, Acute; Glioma; Venous Thrombosis; Facial Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma; Adenocarcinoma; Fasting; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms; Ovarian Neoplasms; Hematopoietic stem cell transplantation (HSCT); Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Solid tumours; Kidney Neoplasms; Recurrence; Carcinoma, Renal Cell; Carcinoma; Stomach Neoplasms; Abdominal Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Liver Neoplasms; Neoplasms, Glandular and Epithelial; Kidney Diseases; Myelodysplastic Syndromes; Myeloproliferative Disorders; Thyroid |
Details
|
Vandetanib |
AZD-6474; CH-331; ZD-6474 |
Approved |
Astrazeneca Pharmaceutical Co Ltd |
Zactima, Caprelsa |
Japan |
Medullary thyroid cancer (MTC) |
Astrazeneca Pharmaceutical Co Ltd |
2011-04-06 |
Thyroid Neoplasms; Paraganglioma; Adenocarcinoma; Precancerous Conditions; Neoplasm Metastasis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Glioma; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Neuroendocrine; Solid tumours; Colorectal Neoplasms; Pleural Effusion; Prostatic Neoplasms; Breast Neoplasms; Medullary thyroid cancer (MTC); Multiple Myeloma; Mesothelioma; Pheochromocytoma; Stomach Neoplasms; Esophageal Neoplasms |
Details
|
Pazopanib Hydrochloride |
GSK-786034; GW-786034B; SB-786034; GW-786034 |
Approved |
Glaxosmithkline Plc, Novartis Pharma Ag |
维全特, Armala, Votrient, Patorma |
Mainland China |
Carcinoma, Renal Cell |
Novartis Pharma Schweiz Ag |
2009-10-19 |
Urogenital Neoplasms; Prostatic Neoplasms; Osteosarcoma; Peritoneal Neoplasms; Gastrointestinal Stromal Tumors; Colorectal Neoplasms; Carcinoma, Small Cell; Leukemia, Myeloid, Acute; Sarcoma, Alveolar Soft Part; Fallopian Tube Neoplasms; Thyroid Neoplasms; Lung Neoplasms; Breast Neoplasms; Glioma; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Uterine Cervical Neoplasms; Macular Degeneration; Melanoma; Neoplasm Metastasis; Carcinoma, Hepatocellular; Thyroid Cancer, Papillary; Neoplasms, Germ Cell and Embryonal; Neoplasms; Ovarian Neoplasms; Solid tumours; Chondrosarcoma; Epistaxis; Telangiectasia, Hereditary Hemorrhagic; Leiomyosarcoma; Carcinoma, Renal Cell; Hemangiosarcoma; Squamous Cell Carcinoma of Head and Neck; Thoracic Neoplasms; Head and Neck Neoplasms; Small Cell Lung Carcinoma; Glioblastoma; Pancreatic Neoplasms; Dermatofibrosarcoma; Central Nervous System Neoplasms; Lymphedema; Liposarcoma; Adenocarcinoma, Follicular; Soft Tissue Neoplasms; Sarcoma |
Details
|
Ripretinib |
DCC-2618 |
Approved |
Deciphera |
擎乐, Qinlock |
United Kingdom |
Gastrointestinal Stromal Tumors |
Deciphera Pharmaceuticals Llc |
2020-05-15 |
Neoplasms; Mastocytosis, Systemic; Gastrointestinal Stromal Tumors |
Details
|
Regorafenib |
DAST; BAY-73-4506 |
Approved |
Bayer AG |
Stivarga, Resihance |
Mainland China |
Gastrointestinal Stromal Tumors |
Bayer Pharma Ag |
2012-09-27 |
Leukemia, Myeloid, Acute; Sarcoma; Gastrinoma; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Bile Duct Neoplasms; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Carcinoma, Adenoid Cystic; Thyroid Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Hepatocellular; Melanoma; Neoplasm Metastasis; Gastrointestinal Neoplasms; Somatostatinoma; Solid tumours; Glucagonoma; Multiple Myeloma; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Transitional Cell; Neoplasms; Glioblastoma; Colonic Neoplasms; Hemangiosarcoma; Carcinoma, Islet Cell; Insulinoma; Carcinoid Tumor; Rectal Neoplasms; Carcinoma, Renal Cell; Ovarian Neoplasms |
Details
|
Axitinib |
AG-013736; CLS-AX; AG-13736; PF-01367866 |
Approved |
Pfizer Pharmaceuticals Ltd (China) |
Inlyta, 英立达 |
Mainland China |
Carcinoma, Renal Cell |
Pfizer Europe Ma Eeig |
2012-01-27 |
Endometriosis; Macular Degeneration; Paraganglioma; Melanoma; Carcinoma, Hepatocellular; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Thyroid Neoplasms; Colorectal Neoplasms; Hepatic Insufficiency; Sarcoma; Prostatic Neoplasms, Castration-Resistant; Carcinoma, Adenoid Cystic; Solid tumours; Multiple Myeloma; Mesothelioma; Adrenal Cortex Neoplasms; Nasopharyngeal Neoplasms; Glioblastoma; Myelodysplastic Syndromes; Skin Neoplasms; Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma; Pheochromocytoma; Carcinoid Tumor; Carcinoma, Renal Cell; Ovarian Neoplasms; Kidney Neoplasms |
Details
|
Midostaurin |
PKC-412; PKC-412A; CGP-41231; CGP-41251 |
Approved |
Novartis Pharma Ag |
Rydapt |
EU |
Leukemia, Myeloid, Acute; Mastocytosis |
Novartis Europharm Ltd |
2017-04-28 |
Hematologic Neoplasms; Leukemia; Mastocytosis, Systemic; Myelodysplastic Syndromes; Leukemia, Mast-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hepatic Insufficiency; Leukemia, Myeloid, Acute; Mastocytosis |
Details
|
Apatinib Mesylate |
YN-968D1 |
Approved |
Advenchen Laboratories |
艾坦, Aitan |
Mainland China |
Stomach Neoplasms |
Jiangsu shengdi Medicine Co Ltd |
2014-10-17 |
Esophageal Squamous Cell Carcinoma; Metaplasia; Breast Neoplasms; Sarcoma; Nasopharyngeal Carcinoma; Cholangiocarcinoma; Neuroblastoma; Bone Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Thyroid Neoplasms; Radiation Injuries; Lymphoma, T-Cell; Lung Neoplasms; Fallopian Tube Neoplasms; Glioma; Neoplasm Metastasis; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma; Neoplasms; Solid tumours; Drug-Related Side Effects and Adverse Reactions; Ovarian Neoplasms; Rhabdomyosarcoma; Biliary Tract Neoplasms; Liver Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Head and Neck Neoplasms; Adenocarcinoma of Lung; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Ovarian Epithelial; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Adenoid Cystic; Soft Tissue Neoplasms; Liver Diseases |
Details
|
Cabozantinib S-malate |
XL-184; BMS-907351 |
Approved |
Exelixis Inc |
Cometriq, Cabometyx |
Japan |
Carcinoma, Renal Cell |
Takeda |
2012-11-29 |
Thyroid Neoplasms; Adenocarcinoma, Follicular; Brain Neoplasms; Sarcoma; Neuroblastoma; Neurofibroma, Plexiform; Prostatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Bile Duct Neoplasms; Central Nervous System Neoplasms; Lymphoma; Leukemia, Myeloid, Acute; Glioma; Carcinoma, Neuroendocrine; Carcinoma, Hepatocellular; Neoplasms, Germ Cell and Embryonal; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Thyroid Cancer, Papillary; Meningioma; Carcinoma, Transitional Cell; Kidney Neoplasms; Ovarian germ cell tumor; Bone metastases; Carcinoma, Renal Cell; Rejection of liver transplantation; Esophageal Neoplasms; Pain; Stomach Neoplasms; Carcinoma, Merkel Cell; Glioblastoma; Seminoma; Solid tumours; Neurofibromatoses; Neoplasms; Salivary Gland Neoplasms; Carcinoma, Papillary; Skin Neoplasms; Kidney Diseases; Neuroendocrine Tumors; Adrenocortical Carcinoma; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma |
Details
|
Nintedanib Esylate |
BIBF-1120 |
Approved |
C.H. Boehringer Sohn Ag & Co. Kg |
Ofev, Vargatef |
EU |
systemic sclerosis-associated interstitial lung disease |
Boehringer Ingelheim International Gmbh |
2014-10-15 |
Genital Neoplasms, Female; Sarcoma; Prostatic Neoplasms; systemic sclerosis-associated interstitial lung disease; Breast Neoplasms; Adenocarcinoma, Clear Cell; Peritoneal Neoplasms; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Oligodendroglioma; Bronchitis; Silicosis; Gliosarcoma; Appendiceal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Idiopathic Pulmonary Fibrosis; Head and Neck Neoplasms; Telangiectasia, Hereditary Hemorrhagic; Bronchiolitis Obliterans; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Rejection of lung transplantation; Carcinoma, Renal Cell; Scleroderma, Systemic; Ovarian Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Glioblastoma; Small Cell Lung Carcinoma; Pulmonary Fibrosis; Lung Diseases, Interstitial; Multiple Myeloma; Asbestosis |
Details
|
Ramucirumab |
IMC-1121; IMC-1C11; LY-3009806; IMC-1121-B; BLA-125477 |
Approved |
Dyax Pharma |
Cyramza |
Mainland China |
Stomach Neoplasms |
Lilly Suzhou Pharmaceutical Co Ltd |
2014-04-21 |
Peritoneal Neoplasms; Breast Neoplasms; Lymphoma, Mantle-Cell; Prostatic Neoplasms; Cholangiocarcinoma; Gastrointestinal Stromal Tumors; Urologic Neoplasms; Ureteral Neoplasms; Colorectal Neoplasms; Urethral Neoplasms; Fallopian Tube Neoplasms; Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms; Melanoma; Carcinoid Tumor; Biliary Tract Neoplasms; Skin Melanoma; Liver Neoplasms; Ovarian Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Rectal Neoplasms; Carcinoma, Renal Cell; Solid tumours; Pancreatic Neoplasms; Colonic Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Ovarian Epithelial; Microsatellite instability-high cancer; Urinary Bladder Neoplasms |
Details
|
Lenvatinib Mesylate |
ER-203492-00; E-7080; MK-7902 |
Approved |
Eisai Co Ltd |
Lenvima, Lenvima/Kisplyx, 乐卫玛, Kisplyx |
Japan |
Carcinoma, Renal Cell |
Merck Sharp & Dohme Corp |
2015-02-13 |
Carcinoma, Adenoid Cystic; Thrombosis; Thyroid Cancer, Papillary; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Melanoma; Esophageal Squamous Cell Carcinoma; Endometrial Neoplasms; Lymphoma; Thyroid Neoplasms; Colorectal Neoplasms; Hepatic Insufficiency; Cholangiocarcinoma; Breast Neoplasms; Sarcoma; Neuroendocrine Tumors; Solid tumours; Urinary Bladder Neoplasms; Adenocarcinoma, Follicular; Liver Diseases; Small Cell Lung Carcinoma; Neoplasms; Kidney Diseases; Thyroid Carcinoma, Anaplastic; Adenocarcinoma of Lung; Rejection of liver transplantation; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Renal Insufficiency; Carcinoma, Renal Cell; Liver Neoplasms; Biliary Tract Neoplasms |
Details
|
Anlotinib Dihydrochloride |
AL-3818 |
Approved |
Advenchen Laboratories, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
福可维 |
Mainland China |
Thyroid Neoplasms |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
2018-05-08 |
Thyroid Neoplasms; Nasopharyngeal Carcinoma; Lymphoma, Extranodal NK-T-Cell; Cholangiocarcinoma; Bile Duct Diseases; Bone Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Gastrointestinal Stromal Tumors; Urologic Neoplasms; Sarcoma, Alveolar Soft Part; Endometrial Neoplasms; Gallbladder Neoplasms; Esophageal Squamous Cell Carcinoma; Medullary thyroid cancer (MTC); Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Glioma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma; Carcinoma, Hepatocellular; Esophageal Diseases; Paraganglioma; Adenocarcinoma; Osteoma; Gastrointestinal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Leiomyosarcoma; Head and Neck Neoplasms; Biliary Tract Neoplasms; Solid tumours; Chondrosarcoma; Liver Neoplasms; Esophageal Neoplasms; Thoracic Neoplasms; Genital Diseases, Female; Stomach Neoplasms; Pheochromocytoma; Digestive System Diseases; Gastrointestinal Diseases; Ovarian Neoplasms; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Tripl |
Details
|
Sunitinib Malate |
PHA-290940; SU-010398; SU-11248; PNU-290940AD; PHA-290940AD; GB-102; PNU-290940; SU-011248-L-malate salt |
Approved |
Pfizer Pharmaceuticals Ltd (China) |
索坦, Sutent |
Japan |
Pancreatic neuroendocrine tumors (pNET) |
Pfizer Inc |
2006-01-26 |
Diabetic macular oedema; Thyroid Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Peritoneal Neoplasms; Astrocytoma; Thymus Neoplasms; Urologic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Thymoma; Neurofibroma, Plexiform; Cholangiocarcinoma; Medullary thyroid cancer (MTC); Brain Neoplasms; Urethral Neoplasms; Prostatic Neoplasms; Sarcoma; Breast Neoplasms; Adrenocortical Carcinoma; Adenocarcinoma; Paraganglioma; Melanoma; Thyroid Cancer, Papillary; Retinal Vein Occlusion; Meningioma; von Hippel-Lindau Disease; Neoplasm Metastasis; Macular Degeneration; Carcinoma, Hepatocellular; Adenocarcinoma, Follicular; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Neoplasms, Gonadal Tissue; Nervous System Neoplasms; Germinoma; Brain metastases; Hemangiopericytoma; Urogenital Neoplasms; Hemangioblastoma; Glioblastoma; Pheochromocytoma; Pelvic Neoplasms; Thoracic Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Carcinoma, Islet Cell; Histiocytom |
Details
|